Differences between clinical trial participants and patients in a population-based registry: The german rectal cancer study vs. the rostock cancer registry

Diseases of the Colon and Rectum

Volumn 52, Issue 3, 2009, Pages 425-437

  Kalata, Paul ^a   Martus, Peter ^b   Zettl, Heike ^a   Rödel, Claus ^c   Hohenberger, Werner ^d   Raab, Rudolf ^e   Becker, Heinz ^f   Liersch, Torsten ^f   Wittekind, Christian ^g   Sauer, Rolf ^d   Fietkau, Rainer ^a,d  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e Clinic Oldenburg   (Germany)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cancer register; Clinical trials; Neoadjuvant and adjuvant chemoradiotherapy; Rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GERMANY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE CARE; RECTUM CANCER; RECTUM RESECTION; SEX DIFFERENCE; TUMOR LOCALIZATION; ADJUVANT THERAPY; CLINICAL TRIAL; COLON RESECTION; COMPARATIVE STUDY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL; RECTUM TUMOR; REGISTER;

AGED; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; COLECTOMY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS; REGISTRIES;

EID: 64549105746     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e318197d13c     Document Type: Article

References (27)

1. Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341:2061Y7.
2. Hotta K, Ueoka H, Kiura K, Tabata M, Tanimoto M. An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer. Lung Cancer 2004;46:61Y76.
3. Jennens RR, Giles GG, Fox RM. Increasing underrepresentation of elderly patients with advanced colorectal or non-smallcell lung cancer in chemotherapy trials. Intern Med J 2006; 36:216Y20.
4. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731Y40.
5. Fietkau R, Zettl H, Klöcking S, Kundt G. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry. Strahlenther Onkol 2004;180:478Y87.
6. Sauer R, Fietkau R, Wittekind C, et al. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol 2001;177:173Y81.
7. Sobin LH, Wittekind C. TNM classification of malignant tumors. 6th ed. New York: Wiley-Liss, 2002.
8. QueiQer W, Hartung G, Kopp-Schneider A, et al. Adjuvant radio-chemotherapy with 5-fluorouracil and leucovorin in stage II and III rectal cancer: 12 months vs. 6 months of therapy: a study of the association for medical oncology of the German Cancer Society. Onkologie 2000;23:334Y9.
9. Gastrointestinal Tumor Study Group. Prolongation of the diseasefree interval in surgically treated rectal carcinoma. N Engl J Med 1985;312:1465Y72.
10. Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01. J Natl Cancer Inst 1988; 80:21Y9.
11. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709Y15.
12. Anonymous. Gastrointestinal Tumor Study Group. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 1992;10:549Y57.
13. O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protractedinfusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502Y7.
14. Tveit KM, Guldvog I, Hagen S, et al. Randomized controlled trial of postoperative radiotherapy and short-term timescheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Br J Surg 1997;84: 1130Y5.
15. Fountzilas G, Zisiadis A, Dafni U, et al. Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: A randomized phase III study conducted by the Hellenic Cooperative Oncology Group. Ann Oncol 1999;10:671Y6.
16. Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000;92:388Y96.
17. Lee JH, Lee JH, Ahn JH, et al. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report. J Clin Oncol 2002;20:1751Y8.
18. Balslev IB, Pedersen M, Teglbjaerg PS, et al. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid: A randomized multicenter study. Cancer 1986; 58:22Y8.
19. Dahl O, Horn A, Morild I, et al. Low-dose preoperative radiation postpones recurrences in operable rectal cancer: Results of a randomized multicenter trial in western Norway. Cancer 1990;66:2286Y94.
20. Treurniet-Donker D, van Putten WL, Wereldsma JC, et al. Postoperative radiation therapy for rectal cancer: An interim analysis of a prospective, randomized multicenter trial in The Netherlands. Cancer 1991;67:2042Y8.
21. Frykholm GJ, Glimelius B, P*hlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: Final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36: 564Y72.
22. Goldberg PA, Nicholls RJ, Porter NH, Love S, Grimsey JE. Long-term results of a randomised trial of short-course lowdose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer 1994;30A: 1602Y6.
23. Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma: a prospective randomized trial. Cancer 1996;75:2269Y75.
24. Anonymous. Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 1996;348:1605Y10.
25. Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 1996; 348:1610Y4.
26. Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638Y46.
27. Krebsinzidenz 2001 und 2002 im Erfassungsgebiet des Gemeinsamen Krebsregisters: Jahresbericht [German]. Gemeinsames Krebsregister der Länder Berlin, Brandenburg, Mecklenburg-Vorpommern, Sachsen-Anhalt und der Freistaaten Sachsen und Thüringen, Berlin, Germany, 2005:24Y8. [See http://www.berlin.de/imperia/md/content/gkr/publikationen/jahresberichte/ jb2001-02.pdf]